http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A#Head http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A#assertion http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A#provenance http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A#pubinfo http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A#assertion http://purl.obolibrary.org/obo/MONDO_0005452 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/MONDO_0005452 http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://go.drugbank.com/drugs/DB01255 http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A#association http://www.w3.org/2000/01/rdf-schema#label Of relevance, lisdexamfetamine dimesylate, a psy- chostimulant approved for the treatment of ADHD, has been recently assessed and approved for the treat- ment of moderate to severe binge eating disorder in adults.5,6 In a phase 2 efficacy and safety trial, pa- tients with binge eating disorder who were prescribed doses of 50 and 70 mg/day doses of lisdexamfetamine demonstrated reduced binge eating days per week, greater binge eating cessation rates, and greater rates of clinical global improvement at 11 weeks compared with the placebo control group http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A#association https://w3id.org/biolink/vocab/has_population_context http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A#cohort http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A#association https://w3id.org/biolink/vocab/publications https://pubmed.ncbi.nlm.nih.gov/28111772/ http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A#association https://w3id.org/biolink/vocab/relation https://w3id.org/um/neurodkg/OffLabelIndication http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A#cohort http://www.w3.org/2000/01/rdf-schema#label Adults http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A#cohort https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Cohort https://go.drugbank.com/drugs/DB01255 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A#provenance http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-7641-6446 http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A#pubinfo http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A#sig http://purl.org/nanopub/x/hasSignature YphypbfC5MLmGaLEX3C5eL9995BcWUP86gvXFkkwD0XlZmDJcmtp0GpkmpeDbzjqR/fny0QBUkDyUCcZzYhHgA5gBgFQIYEV1T4NzbemJsJZ5NIhTypa2rGyC1MMbhga0JB9TxMfO734nihy/R42KQnJXMM0TxXK41nYYb+ls1M= http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A http://purl.org/dc/terms/created 2021-05-31T10:56:11.922+02:00 http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A http://purl.org/dc/terms/creator https://orcid.org/0000-0002-7641-6446 http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A http://purl.org/nanopub/x/supersedes http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAjpBMlw3owYhJUBo3DtsuDlXsNAJ8cnGeWAutDVjuAuI http://purl.org/np/RA8wP3WRlBsWz2MWdiNQcmPEsaPVG8qx64wNxxMtrzc4A https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs